Ximena Rosas-Plaza
Ximena Rosas-Plaza has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Albert J. H. Suurmeijer
Department of Pathology University Medical Center Groningen, University of Groningen Groningen The Netherlands
7 shared publications Gerda de Vries
7 shared publications- Gert Jan Meersma
Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. 1
7 shared publications - Jourik A. Gietema
Departments of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
7 shared publications - Marcel A. T. M. van Vugt
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands
7 shared publications - Steven de Jong
Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
7 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
Cisplatin sensitivity in TC cells and RTK validation on western blot
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
Cisplatin sensitivity in TC cells and RTK validation on western blot
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
MTORC1/2 downstream pathway evaluation in Tera cells
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
MTORC1/2 downstream pathway evaluation in Tera cells
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
MTOR knock down in combination with cisplatin in resistant TC cells
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
MTOR knock down in combination with cisplatin in resistant TC cells
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
PDGFRbeta protein expression in TC cell lines
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
PDGFRbeta protein expression in TC cell lines